Lördag 10 Maj | 07:12:38 Europe / Stockholm

Prenumeration

2025-05-08 07:29:00

Redeye strengthens its positive view of Avensia following a strong Q1 report, showing high growth and a robust EBIT margin. Management saw some tendencies to increased activity in the market, but the lead times remain longer than usual.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/